Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2026-03-09 @ 1:59 AM
Study NCT ID:
NCT02599194
Status:
COMPLETED
Last Update Posted:
2019-01-03
First Post:
2015-11-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
18F-FSPG PET/CT for Cancer Patients on Therapy
Sponsor:
Andrei Iagaru
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-Cell Neoplasm | View |
| None | Estrogen Receptor Negative | View |
| None | HER2/Neu Negative | View |
| None | Metastatic Renal Cell Cancer | View |
| None | Progesterone Receptor Negative | View |
| None | Stage III Mesothelioma | View |
| None | Stage III Renal Cell Cancer | View |
| None | Stage IIIA Breast Cancer | View |
| None | Stage IIIA Non-Small Cell Lung Cancer | View |
| None | Stage IIIB Non-Small Cell Lung Cancer | View |
| None | Stage IIIC Breast Cancer | View |
| None | Stage IV Breast Cancer | View |
| None | Stage IV Mesothelioma | View |
| None | Stage IV Non-Small Cell Lung Cancer | View |
| None | Stage IV Renal Cell Cancer | View |
| None | Triple-Negative Breast Carcinoma | View |
Keywords: